Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,561 to 2,580 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| ACTN4 actinin alpha 4 | 81 HGNC:166 | 1 | 94 | 0 | 0 | 1,537 | 2,438 |
| PCA3 prostate cancer associated 3 | 50652 HGNC:8637 | 0 | 0 | 0 | 0 | 746 | 2,438 |
| PLCB1 phospholipase C beta 1 | 23236 HGNC:15917 | 1 | 43 | 0 | 0 | 1,792 | 2,436 |
| ADRA2A adrenoceptor alpha 2A | 150 HGNC:281 | 1 | 26 | 66 | 1,036 | 1,882 | 2,435 |
| DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 | 10049 HGNC:14888 | 1 | 30 | 0 | 0 | 1,554 | 2,435 |
| FABP5 fatty acid binding protein 5 | 2171 HGNC:3560 | 1 | 92 | 0 | 0 | 1,455 | 2,434 |
| COL6A3 collagen type VI alpha 3 chain | 1293 HGNC:2213 | 1 | 63 | 2 | 66 | 1,534 | 2,433 |
| C2 complement C2 | 717 HGNC:1248 | 1 | 119 | 0 | 0 | 1,292 | 2,431 |
| HNRNPD heterogeneous nuclear ribonucleoprotein D | 3184 HGNC:5036 | 1 | 75 | 0 | 0 | 1,535 | 2,430 |
| COL4A2 collagen type IV alpha 2 chain | 1284 HGNC:2203 | 1 | 115 | 2 | 66 | 1,809 | 2,425 |
| PAM peptidylglycine alpha-amidating monooxygenase | 5066 HGNC:8596 | 1 | 54 | 0 | 0 | 1,033 | 2,423 |
| TFPI2 tissue factor pathway inhibitor 2 | 7980 HGNC:11761 | 1 | 108 | 0 | 0 | 1,270 | 2,421 |
| ADCY10 adenylate cyclase 10 | 55811 HGNC:21285 | 1 | 12 | 0 | 0 | 1,810 | 2,419 |
| SLC17A7 solute carrier family 17 member 7 | 57030 HGNC:16704 | 1 | 29 | 0 | 0 | 2,568 | 2,419 |
| CCL24 C-C motif chemokine ligand 24 | 6369 HGNC:10623 | 1 | 130 | 0 | 0 | 1,457 | 2,418 |
| PTN pleiotrophin | 5764 HGNC:9630 | 1 | 75 | 0 | 0 | 1,319 | 2,418 |
| FLOT1 flotillin 1 | 10211 HGNC:3757 | 1 | 80 | 0 | 0 | 1,742 | 2,417 |
| MIR185 microRNA 185 | 406961 HGNC:31556 | 0 | 0 | 0 | 0 | 766 | 2,417 |
| SOX11 SRY-box transcription factor 11 | 6664 HGNC:11191 | 1 | 34 | 0 | 0 | 1,670 | 2,415 |
| TEAD1 TEA domain transcription factor 1 | 7003 HGNC:11714 | 1 | 34 | 0 | 0 | 1,505 | 2,415 |
Code
curl "https://conductscience.org/api/genes/v1?page=129"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=129
{
"data": {
"total": 193990,
"results": [
{
"id": "81",
"title": "ACTN4: actinin alpha 4",
"summary": "NCBI Gene 81. 1 protein, 94 patents, 0 drugs, 0 trials, 1,537 NIH grants and 2,438 papers.",
"record": "/library/genes/81",
"gene_id": 81,
"symbol": "ACTN4",
"name": "actinin alpha 4",
"hgnc_id": "HGNC:166",
"counts": {
"proteins": 1,
"patents": 94,
"drugs": 0,
"trials": 0,
"grants": 1537,
"papers": 2438
}
},
{
"id": "50652",
"title": "PCA3: prostate cancer associated 3",
"summary": "NCBI Gene 50652. 0 proteins, 0 patents, 0 drugs, 0 trials, 746 NIH grants and 2,438 papers.",
"record": "/library/genes/50652",
"gene_id": 50652,
"symbol": "PCA3",
"name": "prostate cancer associated 3",
"hgnc_id": "HGNC:8637",
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 746,
"papers": 2438
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=130",
"request_id": "MQzOkekRz7IBTAda"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant